- Home
- MAIA vs UCL Comparison
MAIA vs UCL Comparison
Compare MAIA & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- UCL
- Stock Information
- Founded
- MAIA 2018
- UCL 2014
- Country
- MAIA United States
- UCL Hong Kong
- Employees
- MAIA N/A
- UCL N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- UCL Telecommunications Equipment
- Sector
- MAIA Health Care
- UCL Consumer Discretionary
- Exchange
- MAIA Nasdaq
- UCL Nasdaq
- Market Cap
- MAIA 46.7M
- UCL 47.0M
- IPO Year
- MAIA 2022
- UCL 2020
- Fundamental
- Price
- MAIA $1.82
- UCL $1.28
- Analyst Decision
- MAIA
- UCL
- Analyst Count
- MAIA 0
- UCL 0
- Target Price
- MAIA N/A
- UCL N/A
- AVG Volume (30 Days)
- MAIA 341.6K
- UCL 39.1K
- Earning Date
- MAIA 05-09-2025
- UCL 05-23-2025
- Dividend Yield
- MAIA N/A
- UCL N/A
- EPS Growth
- MAIA N/A
- UCL 60.16
- EPS
- MAIA N/A
- UCL 0.12
- Revenue
- MAIA N/A
- UCL $91,635,000.00
- Revenue This Year
- MAIA N/A
- UCL $4.93
- Revenue Next Year
- MAIA N/A
- UCL N/A
- P/E Ratio
- MAIA N/A
- UCL $10.90
- Revenue Growth
- MAIA N/A
- UCL 7.08
- 52 Week Low
- MAIA $1.40
- UCL $0.80
- 52 Week High
- MAIA $5.99
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- MAIA 47.29
- UCL 59.95
- Support Level
- MAIA $1.80
- UCL $1.14
- Resistance Level
- MAIA $2.18
- UCL $1.33
- Average True Range (ATR)
- MAIA 0.29
- UCL 0.08
- MACD
- MAIA -0.03
- UCL 0.03
- Stochastic Oscillator
- MAIA 4.85
- UCL 84.85
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.